Katya Ioffe

Katya Ioffe is a seasoned professional in formulation development, currently serving as a Formulation Project Leader at NeuroDerm, a company within the Mitsubishi Tanabe Pharma Group, since February 2020. Responsibilities include designing and executing pre-formulation and formulation processes, leading project initiatives, and coordinating with cross-functional teams to support regulatory submissions. Additionally, Katya has been a Research and Development Scientist at Rafa Laboratories since October 2016 and a Formulation Research Associate at Chiasma, contributing to the development of new formulations and managing pharmaceutical lab operations. Previously, Katya worked as a Formulation Scientist at LipoCure Ltd., where expertise in liposomal-based nano-drugs, GMP production, and documentation writing was gained. Academic qualifications include a Master’s Degree in Human/Medical Genetics from The Hebrew University of Jerusalem and a Bachelor’s Degree in Biotechnology from The Hadassah Academic College.